Cervicovaginal microbiome dysbiosis is associated with proteome changes related to alterations of the cervicovaginal mucosal barrier

Mucosal Immunology

Volumn 9, Issue 3, 2016, Pages 621-633

  Borgdorff, H ^a   Gautam, R ^b,c   Armstrong, S D ^b   Xia, D ^b   Ndayisaba, G F ^d   Van Teijlingen, N H ^e   Geijtenbeek, T B H ^e   Wastling, J M ^b   Van De Wijgert, J H H M ^b,d  

^a AMSTERDAM INSTITUTE FOR GLOBAL HEALTH AND DEVELOPMENT   (Netherlands)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

^c UNIVERSITY OF PRINCE EDWARD ISLAND   (Canada)

^d Rinda Ubuzima ^*  (Rwanda)

^e ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; CALGRANULIN; CYTOKINE; HISTONE; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; KERATIN; LACTATE DEHYDROGENASE; LACTATE DEHYDROGENASE A; LACTATE DEHYDROGENASE B; LYSOZYME; MUCIN 5AC; MUCIN 5B; PROTEASOME; PROTEINASE; PSORIASIN; UBIQUITIN; UNCLASSIFIED DRUG; AUTACOID; PROTEOME;

ADULT; ARTICLE; CELL DEATH; CERVICOVAGINAL MICROBIOME DYSBIOSIS; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOSKELETON; DISEASE SEVERITY; DYSBIOSIS; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMORAL IMMUNITY; INFECTION RISK; LACTOBACILLUS; LACTOBACILLUS CRISPATUS; LACTOBACILLUS INERS; MASS SPECTROMETRY; MICROARRAY ANALYSIS; MICROBIAL DIVERSITY; MOLECULAR PHYLOGENY; NONHUMAN; PERMEABILITY BARRIER; PRIORITY JOURNAL; PROSTITUTION; PROTEIN CONTENT; PROTEIN DEGRADATION; PROTEOMICS; VAGINA FLORA; VAGINA MUCOSA; ACTIN FILAMENT; DISEASE COURSE; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; MICROFLORA; MUCOSA; PATHOLOGY; PHYSIOLOGY; VAGINA; YOUNG ADULT;

ACTIN CYTOSKELETON; ADULT; CYTOKINES; DISEASE PROGRESSION; DYSBIOSIS; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; INFLAMMATION MEDIATORS; LACTOBACILLUS CRISPATUS; MASS SPECTROMETRY; MICROARRAY ANALYSIS; MICROBIOTA; MUCOUS MEMBRANE; PROTEOME; VAGINA; YOUNG ADULT;

EID: 84964992824     PISSN: 19330219     EISSN: 19353456     Source Type: Journal    
DOI: 10.1038/mi.2015.86     Document Type: Article

References (56)

1. van de Wijgert, J.H. et al. The vaginal microbiota: what have we learned after a decade of molecular characterization? PLoS One 9, e105998 (2014).
2. Klebanoff, M.A., Schwebke, J.R., Zhang, J., Nansel, T.R., Yu, K.F. & Andrews,W.W. Vulvovaginal symptoms in women with bacterial vaginosis. Obstet. Gynecol. 104, 267 (2004).
3. Amsel, R., Totten, P.A., Spiegel, C.A., Chen, K.C.S., Eschenbach, D. & Holmes, K.K. Nonspecific vaginitis-diagnostic criteria and microbial and epidemiologic associations. Am. J. Med. 74, 14-22 (1983).
4. Nugent, R.P., Krohn, M.A. & Hillier, S.L. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J. Clin. Microbiol. 29, 297-301 (1991).
5. Low, N. et al. Intravaginal practices, bacterial vaginosis, and HIV infection in women: individual participant data meta-analysis. PLoS Med. 15, e1000416 (2011).
6. Brotman, R.M. Vaginal microbiome and sexually transmitted infections: an epidemiologic perspective. J. Clin. Invest. 121, 4610-4617 (2011).
7. Boskey, E.R., Cone, R.A., Whaley, K.J. & Moench, T.R. Origins of vaginal acidity: high D/L lactate ratio is consistent with bacteria being the primary source. Hum. Reprod. 16, 1809-1813 (2001).
8. Matu, M.N., Orinda, G.O., Njagi, E.N., Cohen, C.R. & Bukusi, E.A. In vitro inhibitory activity of human vaginal lactobacilli against pathogenic bacteria associated with bacterial vaginosis in Kenyan women. Anaerobe 16, 210-215 (2010).
9. Nikolaitchouk, N., Andersch, B., Falsen, E., Strömbeck, L. & Mattsby-Baltzer, I. The lower genital tract microbiota in relation to cytokine-, SLPI-and endotoxin levels: application of checkerboard DNA-DNA hybridization (CDH). APMIS 116, 263-277 (2008).
10. Wira, C.R., Patel, M.V., Ghosh, M., Mukura, L. & Fahey, J.V. Innate immunity in the human female reproductive tract: endocrine regulation of endogenous antimicrobial protection against HIV and other sexually transmitted infections. Am. J. Reprod. Immunol. 65, 196-211 (2011).
11. Mitchell, C. & Marrazzo, J. Bacterial vaginosis and the cervicovaginal immune response. Am. J. Reprod. Immunol. 71, 555-563 (2014).
12. Yarbrough, V.L., Winkle, S. & Herbst-Kralovetz, M.M. Antimicrobial peptides in the female reproductive tract: A critical component of the mucosal immune barrier with physiological and clinical implications. Hum. Reprod. Update. 21, 353-377 (2014).
13. Kyongo, J.K. et al. Genital tract immunological markers in Sub-Saharan African women with relevance to HIV risk and prevention. AIDS Res. Hum. Retroviruses 30, A233 (2014).
14. Gautam, R. et al. Correlates of the molecular vaginal microbiota composition of African women. BMC Infect. Dis. 15, 86 (2015).
15. Burgener, A. et al. Comprehensive proteomic study identifies serpin and cystatin antiproteases as novel correlates of HIV-1 resistance in the cervicovaginal mucosa of female sex workers. J. Proteome Res. 10, 5139-5149 (2011).
16. Cruciani, F. et al. Proteome profiles of vaginal fluids fromwomen affected by bacterial vaginosis and healthy controls: outcomes of rifaximin treatment. J. Antimicrob. Chemother. 68, 2648-2659 (2013).
17. Hitti, J. et al. Noninvasive diagnosis of intraamniotic infection: proteomic biomarkers in vaginal fluid. Am. J. Obstet. Gynecol. 203, 32.e1-e8 (2010).
18. Liong, S. et al. Proteomic analysis of human cervicovaginal fluid collected before preterm premature rupture of the fetal membranes. Reproduction 145, 137-147 (2013).
19. Pereira, L. et al. Identification of novel protein biomarkers of preterm birth in human cervical-vaginal fluid. J. Proteome Res. 6, 1269-1276 (2007).
20. Zegels, G., Van Raemdonck, G.A., Coen, E.P., Tjalma,W.A. & Van Ostade, X.W. Comprehensive proteomic analysis of human cervical-vaginal fluid using colposcopy samples. Proteome Sci. 7, 17 (2009).
21. Borgdorff, H. et al. Lactobacillus-dominated cervicovaginal microbiota associated with reduced HIV/STI prevalence and genital HIV viral load in African women. ISME J. 8, 1781-1793 (2014).
22. Gipson, I.K. et al. Mucin genes expressed by human female reproductive tract epithelia. Biol. Reprod. 56, 999-1011 (1997).
23. Chen, A. et al. Transient antibody-mucin interactions produce a dynamic molecular shield against viral invasion. Biophys. J. 106, 2028-2036 (2014).
24. Olmsted, S.S., Meyn, L.A., Rohan, L.C. & Hillier, S.L. Glycosidase and proteinase activity of anaerobic gram-negative bacteria isolated from women with bacterial vaginosis. Sex. Transm. Dis. 30, 257-261 (2003).
25. Radtke, A.L., Quayle, A.J. & Herbst-Kralovetz, M.M. Microbial products alter the expression of membrane-associated mucin and antimicrobial peptides in a three-dimensional human endocervical epithelial cell model. Biol. Reprod. 87, 132 (2012).
26. Doerflinger, S.Y., Throop, A.L. & Herbst-Kralovetz, M.M. Bacteria in the vaginal microbiome alter the innate immune response and barrier properties of the human vaginal epithelia in a species-specific manner. J. Infect. Dis. 209, 1989-1999 (2014).
27. Koning, N. et al. Human Milk Blocks DC-SIGN-Pathogen Interaction via MUC1. Front. Immunol. 6, 112 (2015).
28. Ueno, K. et al. MUC1 mucin is a negative regulator of toll-like receptor signaling. Am. J. Respir. Cell Mol. Biol. 38, 263-268 (2008).
29. Ivanov, A.I., Parkos, C.A. & Nusrat, A. Cytoskeletal regulation of epithelial barrier function during inflammation. Am. J. Pathol. 177, 512-524 (2010).
30. Thurman, A.R. & Doncel, G.F. Innate immunity and inflammatory response to Trichomonas vaginalis and bacterial vaginosis: relationship to HIV acquisition. Am. J. Reprod. Immunol. 65, 89-98 (2011).
31. Yeoman, et al. A multi-omic systems-based approach reveals metabolic markers of bacterial vaginosis and insight into the disease. PLoS One 8, e56111 (2013).
32. Macklaim, J.M., Fernandes, A.D., Di Bella, J.M., Hammond, J.A., Reid, G. & Gloor, G.B. Comparative meta-RNA-seq of the vaginal microbiota and differential expression by Lactobacillus iners in health and dysbiosis. Microbiome 1, 12 (2013).
33. Moll, R., Divo, M. & Langbein, L. The human keratins: biology and pathology. Histochem. Cell Biol. 129, 705-733 (2008).
34. Sixt, S.U. & Dahlmann, B. Extracellular, circulating proteasomes and ubiquitin-incidence and relevance. Biochim. Biophys. Acta. 1782, 817-823 (2008).
35. Kloetzel, P.M. & Ossendorp, F. Proteasome and peptidase function in MHC-class-I-mediated antigen presentation. Curr. Opin. Immunol. 16, 76-81 (2004).
36. Bochmann, I. et al. T lymphocytes export proteasomes by way of microparticles: A possible mechanism for generation of extracellular proteasomes. J. Cell Mol. Med. 18, 59-68 (2014).
37. Valore, E.V., Wiley, D.J. & Ganz, T. Reversible deficiency of antimicrobial polypeptides in bacterial vaginosis. Infect. Immun. 74, 5693-5702 (2006).
38. Mildner,M. et al. Psoriasin (S100A7) is amajor Escherichia coli-cidal factor of the female genital tract. Mucosal Immunol. 3, 602-609 (2010).
39. Ashida, H., Kim, M. & Sasakawa, C. Exploitation of the host ubiquitin system by human bacterial pathogens. Nat. Rev. Microbiol. 12, 399-413 (2014).
40. Parseghian, M.H. & Luhrs, K.A. Beyond the walls of the nucleus: The role of histones in cellular signaling and innate immunity. Biochem. Cell Biol. 84, 589-604 (2006).
41. Makarov, A., Denisov, E., Lange, O. & Horning, S. Dynamic range of mass accuracy in LTQ Orbitrap hybrid mass spectrometer. J. Am. Soc. Mass Spectrom. 17, 977-982 (2006).
42. Williams, S.B. et al. Human immunodeficiency virus (HIV)-specific antibody in cervicovaginal lavage specimens obtained from women infected with HIV type 1. Clin. Infect. Dis. 35, 611-617 (2002).
43. Alvarez-Olmos,M.I. et al. Vaginal lactobacilli in adolescents: presence and relationship to local and systemic immunity, and to bacterial vaginosis. Sex. Transm. Dis. 31, 393-400 (2004).
44. Yasodhara, P., Raghunath, M., Sreeramulu, D., Venu, L., Hemalatha, R. & Krishna, T.P. Local immunity in Indian women with bacterial vaginosis. J. Reprod. Immunol. 70, 133-141 (2006).
45. Cauci, S., Monte, R., Driussi, S., Lanzafame, P. & Quadrifoglio, F. Impairment of the mucosal immune system: IgA and IgM cleavage detected in vaginal washings of a subgroup of patients with bacterial vaginosis. J. Infect. Dis. 178, 1698-1706 (1998).
46. Braunstein, S.L. et al. High human immunodeficiency virus incidence in a cohort of Rwandan female sex workers. Sex. Transm. Dis. 38, 385-394 (2011).
47. Dols, J.A. et al. Microarray-based identification of clinically relevant vaginal bacteria in relation to bacterial vaginosis. Am. J. Obstet. Gynecol. 204, 305 (2011).
48. Armstrong, S.D. et al. Comparative analysis of the secretome from a model filarial nematode (Litomosoides sigmodontis) Reveals Maximal Diversity in Gravid Female Parasites. Mol. Cell Proteomics 13, 2527-2544 (2014).
49. Vizcaíno, J.A. et al. ProteomeXchange provides globally co-ordinated proteomics data submission and dissemination. Nat. Biotechnol. 30, 223-226 (2014).
50. Niklasson, O., Skude, G. & Mardh, P.A. Lactate dehydrogenase and its isoenzymes in vaginal fluid in vaginitis/vaginosis cases and in healthy controls. Int. J. STD AIDS 14, 270-273 (2003).
51. Carbon, S., Ireland, A., Mungall, C.J., Shu, S., Marshall, B. & Lewis, S. AmiGO: online access to ontology and annotation data. Bioinformatics 25, 288-289 (2009).
52. UniProt Consortium. Activities at the Universal Protein Resource (UniProt). Nucleic Acids Res. 42, D191-D198 (2014).
53. Mayilyan, K.R. Complement genetics, deficiencies, and disease associations. Protein Cell 3, 487-496 (2012).
54. Teoh, S.S., Whisstock, J.C. & Bird, P.I. Maspin (SERPINB5) is an obligate intracellular serpin. J. Biol. Chem. 285, 10862-10869 (2010).
55. Coux, O., Tanaka, K. & Goldberg, A.L. Structure and functions of the 20S and 26S proteasomes. Annu. Rev. Biochem. 65, 801-847 (1996).
56. Cuzick, J. A Wilcoxon-type test for trend. Stat. Med. 4, 87-90 (1985).